Green Valley Pharmaceutical
Xiaoyan Jin's work experience begins in 2003 as the China Marcom Manager at Pantech Wireless, Inc. Xiaoyan then moved on to work as the Manager of Content & Service Communications China at Sony Mobile Communications from 2006 to 2008. Following that, they served as the Brand PR Manager at Li-Ning (China) Sports Goods Co. Ltd from 2008 to 2010. Xiaoyan Jin then joined SONY (CHINA) CO., LTD as the Digital Communication & PR Manager, where they managed the digital and product PR functions for Sony's consumer electronic home entertainment and audio practice. Xiaoyan also led several company-level BPR projects for the reconstruction of new media ePR systems. After their time at SONY, Xiaoyan Jin served as the Director of Strategic Communication at MediAnd Communication Co., Ltd. from 2016 to 2018. Their next role was the Head of Brand & PR at WuXi NextCODE, where they managed the brand and PR activities for the company. Currently, Xiaoyan Jin is the Head of Digital and Brand at Shanghai Green Valley Pharmaceutical CO.,LTD.
Xiaoyan Jin earned a Bachelor's degree in International Economics from China Foreign Affairs University in the years 1998 to 2002. Additionally, Xiaoyan Jin obtained a certification as a Sony Six Sigma Black Belt from SONY (CHINA) CO., LTD. No specific information regarding the month and year of obtaining the certification is provided.
This person is not in any teams
Green Valley Pharmaceutical
Shanghai Green Valley Pharmaceuticals is an innovative Chinese pharmaceutical company founded in 1997 that pioneers carbohydrate drug development and new treatment strategies in the areas of chronic and complex diseases. It is focused on advancing research programs in neuropsychiatric diseases, cancer, cardiovascular diseases, metabolic diseasesand autoimmune diseases. It has 1,500 employees in China and operates a subsidiary in the United States. It has built the large-scale carbohydrate compound library, the carbohydrate drug API and processing facility, and the world's leading R&D pipeline for carbohydrate drug products.The company upholds the sacred mission of "developing medicines that fulfill the biggest unmet medical needs for human health", explores the pathogenesis of chronic and complex diseases with a holistic view of treatment, and focuses on breakthrough innovation in research and development of carbohydrate drugs. Green Valley is committed to becoming a global leader in carbohydrate drug innovation, providing safer and more effective drugs for patients with chronic and complex diseases, and providing better choice of treatment for diseases and improving the quality of life.